The Home of Clinical Trials
MAC Clinical Research is one of Europe’s largest contract research organisations (CRO) and has headquarters in the UK. Owning a network of Dedicated Research Sites providing extensive reach, MAC also has offices within the EU and the US. Read more …
Latest Clinical Research News
Corporate
What the FDA’s psychedelic guidance and Lilly’s proposed acquisition of AtaiBeckley mean for future clinical trials
The US Food and Drug Administration (FDA) has published its final guidance, Psychedelic Drugs: Considerations for Clinical Investigations, providing clearer
July 21, 2026
Corporate
MAC Clinical Research Progresses Participant Enrolment in Initiator Pharma’s Phase 2a Vulvodynia Study
MAC Clinical Research, supporting Initiator Pharma as a full-service CRO, is pleased to announce the successful progression of participant enrolment
May 8, 2026
Corporate
First Patient Dosed in Phase 1b Study for Generalised Anxiety Disorder
MAC Clinical Research has reached a key milestone in a Phase 1b study sponsored by Newleos Therapeutics investigating NTX-1955, a
April 8, 2026